Dinaciclib is currently undergoing phase II clinical trial in the treatment of non-small-cell lung cancer.

June 21, 2017

prudect name : Dinaciclib is currently undergoing phase II clinical trial in the treatment of non-small-cell lung cancer.
SCH727965

Synonyms: CAS NO: 779353-01-4Molecular Formula: C₂₁H₂₈N₆O₂Molecular Weight: 396.49Purity: 98% minSolubility: In DMSOStorage: -20°C